These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36577870)

  • 21. Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life.
    Cangiano B; Giusti E; Premoli C; Soranna D; Vitale G; Grottoli S; Cambria V; Mantovani G; Mungari R; Maffei P; Dassie F; Giampietro A; Chiloiro S; Tanda ML; Ippolito S; Cannavò S; Ragonese M; Zambon A; Persani L; Fatti LM; Scacchi M;
    Endocrine; 2022 Sep; 77(3):510-518. PubMed ID: 35779206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgically treated acromegaly patients have a similar quality of life whether controlled by surgery or requiring additional medical therapy (QuaLAT Study).
    Arshad MF; Ogunleye O; Ross R; Debono M
    Pituitary; 2021 Oct; 24(5):768-777. PubMed ID: 33982222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life.
    Geraedts VJ; Dimopoulou C; Auer M; Schopohl J; Stalla GK; Sievers C
    Front Endocrinol (Lausanne); 2014; 5():229. PubMed ID: 25610427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved AcroQoL scores in acromegaly after sagittal split ramus osteotomy with Le Fort I osteotomy.
    Taguchi T; Kimizuka S; Takano K
    Endocrinol Diabetes Metab Case Rep; 2021 Apr; 2021():. PubMed ID: 33960325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant.
    Neggers SJ; van Aken MO; de Herder WW; Feelders RA; Janssen JA; Badia X; Webb SM; van der Lely AJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3853-9. PubMed ID: 18647806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total score or subscales in scoring the acromegaly quality of life questionnaire: using novel confirmatory methods to compare scoring options.
    Felt JM; Depaoli SA; Pereira AM; Biermasz NR; Tiemensma J
    Eur J Endocrinol; 2015 Jul; 173(1):37-42. PubMed ID: 25872514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related Quality of Life in Acromegaly Patients: Results from Generic and Disease-specific Questionnaires.
    Oliveira BA; Araújo B; Dos Santos TM; Ongaratti BR; Leães Rech CGS; Ferreira NP; S Pereira-Lima JF; da C Oliveira M
    Indian J Endocrinol Metab; 2020; 24(5):402-405. PubMed ID: 33489844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.
    Matta MP; Couture E; Cazals L; Vezzosi D; Bennet A; Caron P
    Eur J Endocrinol; 2008 Mar; 158(3):305-10. PubMed ID: 18299462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment.
    Yamamoto N; Urai S; Fukuoka H; Yamamoto M; Yoshida K; Suzuki M; Shichi H; Fujita Y; Kanie K; Iguchi G; Takahashi Y; Ogawa W
    Front Endocrinol (Lausanne); 2022; 13():819330. PubMed ID: 35185799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
    Webb SM; Badia X; Surinach NL;
    Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life in patients with acromegaly receiving lanreotide autogel: a real-world observational study.
    Bolanowski M; Hubalewska-Dydejczyk A; Kos-Kudła B; Ruchała M; Witek P; Zgliczyński W; Houchard A; Bartmańska M
    Endokrynol Pol; 2021; 72(5):512-519. PubMed ID: 34647602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity.
    Fatti LM; Cangiano B; Vitale G; Persani L; Mantovani G; Sala E; Arosio M; Maffei P; Dassie F; Mormando M; Giampietro A; Tanda L; Masiello ER; Nazzari E; Ferone D; Corbetta S; Passeri E; Guaraldi F; Grottoli S; Cannavò S; Torre MLT; Soranna D; Zambon A; Cavagnini F; Scacchi M;
    Pituitary; 2019 Oct; 22(5):552-560. PubMed ID: 31032537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vertebral Fractures Associated with Spinal Sagittal Imbalance and Quality of Life in Acromegaly: A Radiographic Study with EOS 2D/3D Technology.
    Cellini M; Biamonte E; Mazza M; Trenti N; Ragucci P; Milani D; Ferrante E; Rossini Z; Lavezzi E; Sala E; Mantovani G; Arosio M; Fornari M; Balzarini L; Lania AG; Mazziotti G
    Neuroendocrinology; 2021; 111(8):775-785. PubMed ID: 32980840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study.
    Marazuela M; Blanco C; Bernabeu I; Menendez E; Villar R; Paja M; Sampedro-Nuñez M; Samaniego ML; Díaz-Muñoz M; Sánchez-Cenizo L
    Endocrine; 2022 Feb; 75(2):525-536. PubMed ID: 34668173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.
    Vandeva S; Yaneva M; Natchev E; Elenkova A; Kalinov K; Zacharieva S
    Endocrine; 2015 Aug; 49(3):774-82. PubMed ID: 25561370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations of clinical parameters with quality of life in patients with acromegaly: Taiwan Acromegaly Registry.
    Tseng FY; Chen ST; Chen JF; Huang TS; Lin JD; Wang PW; Huey-Herng Sheu W; Chang TC;
    J Formos Med Assoc; 2019 Nov; 118(11):1488-1493. PubMed ID: 31147197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in female patients with acromegaly.
    Celik O; Kadioglu P
    J Endocrinol Invest; 2013 Jun; 36(6):412-6. PubMed ID: 23211278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.
    Chin SO; Chung CH; Chung YS; Kim BJ; Kim HY; Kim IJ; Kim JG; Kim MS; Kim SY; Lee EJ; Lee KY; Kim SW
    BMJ Open; 2015 Jun; 5(6):e006898. PubMed ID: 26063564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Executive functioning and quality of life in acromegaly.
    Solomon E; Brănișteanu D; Dumbravă A; Solomon RG; Kiss L; Glod M; Preda C
    Psychol Res Behav Manag; 2019; 12():39-44. PubMed ID: 30655710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and quality of life responses to octreotide-LAR in acromegaly.
    Mangupli R; Camperos P; Webb SM
    Pituitary; 2014 Dec; 17(6):495-9. PubMed ID: 24178448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.